Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2011-04-14 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
华泰联合证券有限责任公司关于公司《2010年度内部控制自我评价报告》的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an opinion from Huatai United Securities on the "2010 Annual Internal Control Self-Evaluation Report" of Jiashitang Pharmaceutical Co., Ltd. It details the verification work performed by the sponsor institution on the company's internal control report for the year 2010. The content focuses on internal control environment, risk assessment, internal control systems, procedures, communication, supervision, and the company's self-evaluation of internal control effectiveness. It is a verification or audit opinion on an internal control report rather than the full internal control report itself. The document is about the audit or verification of internal control, which aligns with the category of Audit Report / Information (AR). The document length is over 5,000 characters and contains substantive content, not just an announcement or certification letter. Therefore, the best classification is AR (Audit Report / Information). FY 2010
2011-04-14 Chinese
董事会关于证券投资情况的专项说明
Regulatory Filings Classification · 95% confidence The document is a special statement from the board of directors regarding the company's securities investment situation for the year 2010. It details the securities held, investment activities (or lack thereof), internal control execution, and opinions from the sponsor institution and independent directors. The document is relatively short (1087 characters) and focuses on a specific aspect of securities investment rather than presenting comprehensive financial data or full financial statements. It is not an annual report, audit report, or earnings release. It is also not a regulatory filing or announcement of a report publication. The content fits best with a Regulatory Filings (RNS) category as it is a specific disclosure about securities investment activities and internal controls, without constituting a full financial report or other specialized filing type.
2011-04-14 Chinese
第三届监事会第七次会议的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 7th meeting of the 3rd Supervisory Board of 嘉事堂药业股份有限公司, held on April 12, 2011. It includes multiple agenda items such as the 2010 Supervisory Board work report, internal control self-evaluation report, 2010 financial statements audited by an accounting firm, profit distribution and capital reserve conversion plan, 2010 annual report and its summary, and the use of raised funds. The document contains voting results and references to other company announcements for detailed reports. The document is not the full annual report itself but an announcement of the supervisory board meeting decisions and approvals related to the annual report and other financial matters. The document length is 3337 characters, which is relatively short and consistent with an announcement rather than a full report. It also references other announcements (e.g., 2011-002, 2011-003) where the full annual report and summary are published. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of meeting resolutions and approvals related to the annual report and financial matters, not the annual report itself.
2011-04-14 Chinese
关于召开2010年度股东大会的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the convening of the 2010 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It details the meeting date, location, agenda items to be discussed and voted on, including reports and financial statements from 2010, and procedural information for shareholders to attend and vote. The document does not contain the actual reports or financial data but rather serves as a notice to shareholders about the AGM and its agenda. The document length is 2909 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2011-04-14 Chinese
第三届董事会第七次会议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the third session of the seventh board meeting of 嘉事堂药业股份有限公司 held on April 12, 2011. It includes summaries of the 2010 annual work report, financial results, profit distribution plans, internal control reports, appointment of senior management, amendments to company articles, and proposals for the upcoming 2010 annual shareholders meeting. The document contains voting results for each agenda item and references to other company announcements for full reports. It is not the full annual report itself but a board meeting announcement detailing management and board decisions and proposals to be submitted to the shareholders. This fits the category of Board/Management Information (MANG) as it primarily concerns board meeting proceedings, management reports, and appointments rather than the full annual report or financial statements. The document length (6959 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is MANG with high confidence.
2011-04-14 Chinese
2010年年度报告
Annual Report Classification · 100% confidence The document is titled '2010 年度报告' which translates to '2010 Annual Report'. It includes detailed sections such as company basic information, financial data and business data summary, share capital changes and shareholder information, board and senior management details, corporate governance structure, shareholder meeting summaries, board reports, supervisory reports, important matters, and financial reports. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It also mentions an audit report with an unqualified opinion, which is typical in annual reports. The presence of comprehensive financial data, management discussion, and governance information confirms this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2010
2011-04-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.